0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antifungal Creams Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-22W11489
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Antifungal Creams Market Research Report 2022
BUY CHAPTERS

Global Antifungal Creams Market Research Report 2025

Code: QYRE-Auto-22W11489
Report
January 2025
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antifungal Creams Market

The global market for Antifungal Creams was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Antifungal Creams is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Antifungal Creams is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Antifungal Creams include Medline, Lamisil, Triple Paste, Kerasal, Coloplast, FungiCure, Puriya, Family Care, MAJESTIC PURE, Ebanel, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antifungal Creams, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antifungal Creams.
The Antifungal Creams market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antifungal Creams market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antifungal Creams manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antifungal Creams Market Report

Report Metric Details
Report Name Antifungal Creams Market
Segment by Type
  • Tube Package
  • Bottle Package
Segment by Application
  • Adult
  • Child
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medline, Lamisil, Triple Paste, Kerasal, Coloplast, FungiCure, Puriya, Family Care, MAJESTIC PURE, Ebanel, Candida Freedom, Johnson & Johnson, Pfizer, Novartis, Bayer, GSK (GlaxoSmithKline), Cipla, Mylan, Taro Pharmaceuticals, Dr. Reddy's Laboratories, Sandoz, Fougera
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antifungal Creams manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antifungal Creams in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Antifungal Creams Market report?

Ans: The main players in the Antifungal Creams Market are Medline, Lamisil, Triple Paste, Kerasal, Coloplast, FungiCure, Puriya, Family Care, MAJESTIC PURE, Ebanel, Candida Freedom, Johnson & Johnson, Pfizer, Novartis, Bayer, GSK (GlaxoSmithKline), Cipla, Mylan, Taro Pharmaceuticals, Dr. Reddy's Laboratories, Sandoz, Fougera

What are the Application segmentation covered in the Antifungal Creams Market report?

Ans: The Applications covered in the Antifungal Creams Market report are Adult, Child

What are the Type segmentation covered in the Antifungal Creams Market report?

Ans: The Types covered in the Antifungal Creams Market report are Tube Package, Bottle Package

1 Antifungal Creams Market Overview
1.1 Product Definition
1.2 Antifungal Creams by Type
1.2.1 Global Antifungal Creams Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tube Package
1.2.3 Bottle Package
1.3 Antifungal Creams by Application
1.3.1 Global Antifungal Creams Market Value by Application (2024 VS 2031)
1.3.2 Adult
1.3.3 Child
1.4 Global Antifungal Creams Market Size Estimates and Forecasts
1.4.1 Global Antifungal Creams Revenue 2020-2031
1.4.2 Global Antifungal Creams Sales 2020-2031
1.4.3 Global Antifungal Creams Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antifungal Creams Market Competition by Manufacturers
2.1 Global Antifungal Creams Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antifungal Creams Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antifungal Creams Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antifungal Creams, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antifungal Creams, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antifungal Creams, Product Type & Application
2.7 Global Key Manufacturers of Antifungal Creams, Date of Enter into This Industry
2.8 Global Antifungal Creams Market Competitive Situation and Trends
2.8.1 Global Antifungal Creams Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antifungal Creams Players Market Share by Revenue
2.8.3 Global Antifungal Creams Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antifungal Creams Market Scenario by Region
3.1 Global Antifungal Creams Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antifungal Creams Sales by Region: 2020-2031
3.2.1 Global Antifungal Creams Sales by Region: 2020-2025
3.2.2 Global Antifungal Creams Sales by Region: 2026-2031
3.3 Global Antifungal Creams Revenue by Region: 2020-2031
3.3.1 Global Antifungal Creams Revenue by Region: 2020-2025
3.3.2 Global Antifungal Creams Revenue by Region: 2026-2031
3.4 North America Antifungal Creams Market Facts & Figures by Country
3.4.1 North America Antifungal Creams Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antifungal Creams Sales by Country (2020-2031)
3.4.3 North America Antifungal Creams Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antifungal Creams Market Facts & Figures by Country
3.5.1 Europe Antifungal Creams Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antifungal Creams Sales by Country (2020-2031)
3.5.3 Europe Antifungal Creams Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antifungal Creams Market Facts & Figures by Region
3.6.1 Asia Pacific Antifungal Creams Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antifungal Creams Sales by Region (2020-2031)
3.6.3 Asia Pacific Antifungal Creams Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Antifungal Creams Market Facts & Figures by Country
3.7.1 Latin America Antifungal Creams Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antifungal Creams Sales by Country (2020-2031)
3.7.3 Latin America Antifungal Creams Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antifungal Creams Market Facts & Figures by Country
3.8.1 Middle East and Africa Antifungal Creams Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antifungal Creams Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antifungal Creams Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antifungal Creams Sales by Type (2020-2031)
4.1.1 Global Antifungal Creams Sales by Type (2020-2025)
4.1.2 Global Antifungal Creams Sales by Type (2026-2031)
4.1.3 Global Antifungal Creams Sales Market Share by Type (2020-2031)
4.2 Global Antifungal Creams Revenue by Type (2020-2031)
4.2.1 Global Antifungal Creams Revenue by Type (2020-2025)
4.2.2 Global Antifungal Creams Revenue by Type (2026-2031)
4.2.3 Global Antifungal Creams Revenue Market Share by Type (2020-2031)
4.3 Global Antifungal Creams Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antifungal Creams Sales by Application (2020-2031)
5.1.1 Global Antifungal Creams Sales by Application (2020-2025)
5.1.2 Global Antifungal Creams Sales by Application (2026-2031)
5.1.3 Global Antifungal Creams Sales Market Share by Application (2020-2031)
5.2 Global Antifungal Creams Revenue by Application (2020-2031)
5.2.1 Global Antifungal Creams Revenue by Application (2020-2025)
5.2.2 Global Antifungal Creams Revenue by Application (2026-2031)
5.2.3 Global Antifungal Creams Revenue Market Share by Application (2020-2031)
5.3 Global Antifungal Creams Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medline
6.1.1 Medline Company Information
6.1.2 Medline Description and Business Overview
6.1.3 Medline Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medline Antifungal Creams Product Portfolio
6.1.5 Medline Recent Developments/Updates
6.2 Lamisil
6.2.1 Lamisil Company Information
6.2.2 Lamisil Description and Business Overview
6.2.3 Lamisil Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Lamisil Antifungal Creams Product Portfolio
6.2.5 Lamisil Recent Developments/Updates
6.3 Triple Paste
6.3.1 Triple Paste Company Information
6.3.2 Triple Paste Description and Business Overview
6.3.3 Triple Paste Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Triple Paste Antifungal Creams Product Portfolio
6.3.5 Triple Paste Recent Developments/Updates
6.4 Kerasal
6.4.1 Kerasal Company Information
6.4.2 Kerasal Description and Business Overview
6.4.3 Kerasal Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Kerasal Antifungal Creams Product Portfolio
6.4.5 Kerasal Recent Developments/Updates
6.5 Coloplast
6.5.1 Coloplast Company Information
6.5.2 Coloplast Description and Business Overview
6.5.3 Coloplast Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Coloplast Antifungal Creams Product Portfolio
6.5.5 Coloplast Recent Developments/Updates
6.6 FungiCure
6.6.1 FungiCure Company Information
6.6.2 FungiCure Description and Business Overview
6.6.3 FungiCure Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.6.4 FungiCure Antifungal Creams Product Portfolio
6.6.5 FungiCure Recent Developments/Updates
6.7 Puriya
6.7.1 Puriya Company Information
6.7.2 Puriya Description and Business Overview
6.7.3 Puriya Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Puriya Antifungal Creams Product Portfolio
6.7.5 Puriya Recent Developments/Updates
6.8 Family Care
6.8.1 Family Care Company Information
6.8.2 Family Care Description and Business Overview
6.8.3 Family Care Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Family Care Antifungal Creams Product Portfolio
6.8.5 Family Care Recent Developments/Updates
6.9 MAJESTIC PURE
6.9.1 MAJESTIC PURE Company Information
6.9.2 MAJESTIC PURE Description and Business Overview
6.9.3 MAJESTIC PURE Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.9.4 MAJESTIC PURE Antifungal Creams Product Portfolio
6.9.5 MAJESTIC PURE Recent Developments/Updates
6.10 Ebanel
6.10.1 Ebanel Company Information
6.10.2 Ebanel Description and Business Overview
6.10.3 Ebanel Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ebanel Antifungal Creams Product Portfolio
6.10.5 Ebanel Recent Developments/Updates
6.11 Candida Freedom
6.11.1 Candida Freedom Company Information
6.11.2 Candida Freedom Description and Business Overview
6.11.3 Candida Freedom Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Candida Freedom Antifungal Creams Product Portfolio
6.11.5 Candida Freedom Recent Developments/Updates
6.12 Johnson & Johnson
6.12.1 Johnson & Johnson Company Information
6.12.2 Johnson & Johnson Description and Business Overview
6.12.3 Johnson & Johnson Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Johnson & Johnson Antifungal Creams Product Portfolio
6.12.5 Johnson & Johnson Recent Developments/Updates
6.13 Pfizer
6.13.1 Pfizer Company Information
6.13.2 Pfizer Description and Business Overview
6.13.3 Pfizer Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Pfizer Antifungal Creams Product Portfolio
6.13.5 Pfizer Recent Developments/Updates
6.14 Novartis
6.14.1 Novartis Company Information
6.14.2 Novartis Description and Business Overview
6.14.3 Novartis Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Novartis Antifungal Creams Product Portfolio
6.14.5 Novartis Recent Developments/Updates
6.15 Bayer
6.15.1 Bayer Company Information
6.15.2 Bayer Description and Business Overview
6.15.3 Bayer Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Bayer Antifungal Creams Product Portfolio
6.15.5 Bayer Recent Developments/Updates
6.16 GSK (GlaxoSmithKline)
6.16.1 GSK (GlaxoSmithKline) Company Information
6.16.2 GSK (GlaxoSmithKline) Description and Business Overview
6.16.3 GSK (GlaxoSmithKline) Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.16.4 GSK (GlaxoSmithKline) Antifungal Creams Product Portfolio
6.16.5 GSK (GlaxoSmithKline) Recent Developments/Updates
6.17 Cipla
6.17.1 Cipla Company Information
6.17.2 Cipla Description and Business Overview
6.17.3 Cipla Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Cipla Antifungal Creams Product Portfolio
6.17.5 Cipla Recent Developments/Updates
6.18 Mylan
6.18.1 Mylan Company Information
6.18.2 Mylan Description and Business Overview
6.18.3 Mylan Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Mylan Antifungal Creams Product Portfolio
6.18.5 Mylan Recent Developments/Updates
6.19 Taro Pharmaceuticals
6.19.1 Taro Pharmaceuticals Company Information
6.19.2 Taro Pharmaceuticals Description and Business Overview
6.19.3 Taro Pharmaceuticals Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Taro Pharmaceuticals Antifungal Creams Product Portfolio
6.19.5 Taro Pharmaceuticals Recent Developments/Updates
6.20 Dr. Reddy's Laboratories
6.20.1 Dr. Reddy's Laboratories Company Information
6.20.2 Dr. Reddy's Laboratories Description and Business Overview
6.20.3 Dr. Reddy's Laboratories Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Dr. Reddy's Laboratories Antifungal Creams Product Portfolio
6.20.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.21 Sandoz
6.21.1 Sandoz Company Information
6.21.2 Sandoz Description and Business Overview
6.21.3 Sandoz Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Sandoz Antifungal Creams Product Portfolio
6.21.5 Sandoz Recent Developments/Updates
6.22 Fougera
6.22.1 Fougera Company Information
6.22.2 Fougera Description and Business Overview
6.22.3 Fougera Antifungal Creams Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Fougera Antifungal Creams Product Portfolio
6.22.5 Fougera Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antifungal Creams Industry Chain Analysis
7.2 Antifungal Creams Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antifungal Creams Production Mode & Process Analysis
7.4 Antifungal Creams Sales and Marketing
7.4.1 Antifungal Creams Sales Channels
7.4.2 Antifungal Creams Distributors
7.5 Antifungal Creams Customer Analysis
8 Antifungal Creams Market Dynamics
8.1 Antifungal Creams Industry Trends
8.2 Antifungal Creams Market Drivers
8.3 Antifungal Creams Market Challenges
8.4 Antifungal Creams Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Antifungal Creams Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Antifungal Creams Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Antifungal Creams Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Antifungal Creams Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Antifungal Creams Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Antifungal Creams Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Antifungal Creams Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Antifungal Creams Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Antifungal Creams, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Antifungal Creams, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Antifungal Creams, Product Type & Application
 Table 12. Global Key Manufacturers of Antifungal Creams, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antifungal Creams by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antifungal Creams as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antifungal Creams Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Antifungal Creams Sales by Region (2020-2025) & (K Units)
 Table 18. Global Antifungal Creams Sales Market Share by Region (2020-2025)
 Table 19. Global Antifungal Creams Sales by Region (2026-2031) & (K Units)
 Table 20. Global Antifungal Creams Sales Market Share by Region (2026-2031)
 Table 21. Global Antifungal Creams Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Antifungal Creams Revenue Market Share by Region (2020-2025)
 Table 23. Global Antifungal Creams Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Antifungal Creams Revenue Market Share by Region (2026-2031)
 Table 25. North America Antifungal Creams Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Antifungal Creams Sales by Country (2020-2025) & (K Units)
 Table 27. North America Antifungal Creams Sales by Country (2026-2031) & (K Units)
 Table 28. North America Antifungal Creams Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Antifungal Creams Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Antifungal Creams Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Antifungal Creams Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Antifungal Creams Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Antifungal Creams Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Antifungal Creams Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Antifungal Creams Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Antifungal Creams Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Antifungal Creams Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Antifungal Creams Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Antifungal Creams Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Antifungal Creams Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Antifungal Creams Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Antifungal Creams Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Antifungal Creams Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antifungal Creams Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Antifungal Creams Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Antifungal Creams Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Antifungal Creams Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Antifungal Creams Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Antifungal Creams Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Antifungal Creams Sales (K Units) by Type (2020-2025)
 Table 51. Global Antifungal Creams Sales (K Units) by Type (2026-2031)
 Table 52. Global Antifungal Creams Sales Market Share by Type (2020-2025)
 Table 53. Global Antifungal Creams Sales Market Share by Type (2026-2031)
 Table 54. Global Antifungal Creams Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Antifungal Creams Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Antifungal Creams Revenue Market Share by Type (2020-2025)
 Table 57. Global Antifungal Creams Revenue Market Share by Type (2026-2031)
 Table 58. Global Antifungal Creams Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Antifungal Creams Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Antifungal Creams Sales (K Units) by Application (2020-2025)
 Table 61. Global Antifungal Creams Sales (K Units) by Application (2026-2031)
 Table 62. Global Antifungal Creams Sales Market Share by Application (2020-2025)
 Table 63. Global Antifungal Creams Sales Market Share by Application (2026-2031)
 Table 64. Global Antifungal Creams Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Antifungal Creams Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Antifungal Creams Revenue Market Share by Application (2020-2025)
 Table 67. Global Antifungal Creams Revenue Market Share by Application (2026-2031)
 Table 68. Global Antifungal Creams Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Antifungal Creams Price (US$/Unit) by Application (2026-2031)
 Table 70. Medline Company Information
 Table 71. Medline Description and Business Overview
 Table 72. Medline Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Medline Antifungal Creams Product
 Table 74. Medline Recent Developments/Updates
 Table 75. Lamisil Company Information
 Table 76. Lamisil Description and Business Overview
 Table 77. Lamisil Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Lamisil Antifungal Creams Product
 Table 79. Lamisil Recent Developments/Updates
 Table 80. Triple Paste Company Information
 Table 81. Triple Paste Description and Business Overview
 Table 82. Triple Paste Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Triple Paste Antifungal Creams Product
 Table 84. Triple Paste Recent Developments/Updates
 Table 85. Kerasal Company Information
 Table 86. Kerasal Description and Business Overview
 Table 87. Kerasal Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Kerasal Antifungal Creams Product
 Table 89. Kerasal Recent Developments/Updates
 Table 90. Coloplast Company Information
 Table 91. Coloplast Description and Business Overview
 Table 92. Coloplast Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Coloplast Antifungal Creams Product
 Table 94. Coloplast Recent Developments/Updates
 Table 95. FungiCure Company Information
 Table 96. FungiCure Description and Business Overview
 Table 97. FungiCure Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. FungiCure Antifungal Creams Product
 Table 99. FungiCure Recent Developments/Updates
 Table 100. Puriya Company Information
 Table 101. Puriya Description and Business Overview
 Table 102. Puriya Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Puriya Antifungal Creams Product
 Table 104. Puriya Recent Developments/Updates
 Table 105. Family Care Company Information
 Table 106. Family Care Description and Business Overview
 Table 107. Family Care Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Family Care Antifungal Creams Product
 Table 109. Family Care Recent Developments/Updates
 Table 110. MAJESTIC PURE Company Information
 Table 111. MAJESTIC PURE Description and Business Overview
 Table 112. MAJESTIC PURE Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. MAJESTIC PURE Antifungal Creams Product
 Table 114. MAJESTIC PURE Recent Developments/Updates
 Table 115. Ebanel Company Information
 Table 116. Ebanel Description and Business Overview
 Table 117. Ebanel Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Ebanel Antifungal Creams Product
 Table 119. Ebanel Recent Developments/Updates
 Table 120. Candida Freedom Company Information
 Table 121. Candida Freedom Description and Business Overview
 Table 122. Candida Freedom Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Candida Freedom Antifungal Creams Product
 Table 124. Candida Freedom Recent Developments/Updates
 Table 125. Johnson & Johnson Company Information
 Table 126. Johnson & Johnson Description and Business Overview
 Table 127. Johnson & Johnson Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Johnson & Johnson Antifungal Creams Product
 Table 129. Johnson & Johnson Recent Developments/Updates
 Table 130. Pfizer Company Information
 Table 131. Pfizer Description and Business Overview
 Table 132. Pfizer Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Pfizer Antifungal Creams Product
 Table 134. Pfizer Recent Developments/Updates
 Table 135. Novartis Company Information
 Table 136. Novartis Description and Business Overview
 Table 137. Novartis Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Novartis Antifungal Creams Product
 Table 139. Novartis Recent Developments/Updates
 Table 140. Bayer Company Information
 Table 141. Bayer Description and Business Overview
 Table 142. Bayer Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Bayer Antifungal Creams Product
 Table 144. Bayer Recent Developments/Updates
 Table 145. GSK (GlaxoSmithKline) Company Information
 Table 146. GSK (GlaxoSmithKline) Description and Business Overview
 Table 147. GSK (GlaxoSmithKline) Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. GSK (GlaxoSmithKline) Antifungal Creams Product
 Table 149. GSK (GlaxoSmithKline) Recent Developments/Updates
 Table 150. Cipla Company Information
 Table 151. Cipla Description and Business Overview
 Table 152. Cipla Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Cipla Antifungal Creams Product
 Table 154. Cipla Recent Developments/Updates
 Table 155. Mylan Company Information
 Table 156. Mylan Description and Business Overview
 Table 157. Mylan Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Mylan Antifungal Creams Product
 Table 159. Mylan Recent Developments/Updates
 Table 160. Taro Pharmaceuticals Company Information
 Table 161. Taro Pharmaceuticals Description and Business Overview
 Table 162. Taro Pharmaceuticals Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Taro Pharmaceuticals Antifungal Creams Product
 Table 164. Taro Pharmaceuticals Recent Developments/Updates
 Table 165. Dr. Reddy's Laboratories Company Information
 Table 166. Dr. Reddy's Laboratories Description and Business Overview
 Table 167. Dr. Reddy's Laboratories Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Dr. Reddy's Laboratories Antifungal Creams Product
 Table 169. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 170. Sandoz Company Information
 Table 171. Sandoz Description and Business Overview
 Table 172. Sandoz Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Sandoz Antifungal Creams Product
 Table 174. Sandoz Recent Developments/Updates
 Table 175. Fougera Company Information
 Table 176. Fougera Description and Business Overview
 Table 177. Fougera Antifungal Creams Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Fougera Antifungal Creams Product
 Table 179. Fougera Recent Developments/Updates
 Table 180. Key Raw Materials Lists
 Table 181. Raw Materials Key Suppliers Lists
 Table 182. Antifungal Creams Distributors List
 Table 183. Antifungal Creams Customers List
 Table 184. Antifungal Creams Market Trends
 Table 185. Antifungal Creams Market Drivers
 Table 186. Antifungal Creams Market Challenges
 Table 187. Antifungal Creams Market Restraints
 Table 188. Research Programs/Design for This Report
 Table 189. Key Data Information from Secondary Sources
 Table 190. Key Data Information from Primary Sources
 Table 191. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antifungal Creams
 Figure 2. Global Antifungal Creams Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antifungal Creams Market Share by Type: 2024 & 2031
 Figure 4. Tube Package Product Picture
 Figure 5. Bottle Package Product Picture
 Figure 6. Global Antifungal Creams Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Antifungal Creams Market Share by Application: 2024 & 2031
 Figure 8. Adult
 Figure 9. Child
 Figure 10. Global Antifungal Creams Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Antifungal Creams Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Antifungal Creams Sales (2020-2031) & (K Units)
 Figure 13. Global Antifungal Creams Average Price (US$/Unit) & (2020-2031)
 Figure 14. Antifungal Creams Report Years Considered
 Figure 15. Antifungal Creams Sales Share by Manufacturers in 2024
 Figure 16. Global Antifungal Creams Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Antifungal Creams Players: Market Share by Revenue in Antifungal Creams in 2024
 Figure 18. Antifungal Creams Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Antifungal Creams Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Antifungal Creams Sales Market Share by Country (2020-2031)
 Figure 21. North America Antifungal Creams Revenue Market Share by Country (2020-2031)
 Figure 22. United States Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Antifungal Creams Sales Market Share by Country (2020-2031)
 Figure 25. Europe Antifungal Creams Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Antifungal Creams Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Antifungal Creams Revenue Market Share by Region (2020-2031)
 Figure 33. China Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Antifungal Creams Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Antifungal Creams Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Antifungal Creams Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Antifungal Creams Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Antifungal Creams Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Antifungal Creams by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Antifungal Creams by Type (2020-2031)
 Figure 54. Global Antifungal Creams Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Antifungal Creams by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Antifungal Creams by Application (2020-2031)
 Figure 57. Global Antifungal Creams Price (US$/Unit) by Application (2020-2031)
 Figure 58. Antifungal Creams Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners